Completed PHASE2 INTERVENTIONAL NCT00324454

Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

A Pilot Trial of Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

Sponsor: Duke University

Conditions Amyotrophic Lateral Sclerosis Motor Neuron Disease Primary Lateral Sclerosis Progressive Muscular Atrophy

Updated 6 times since 2017 Last updated: Jun 17, 2013 Started: May 31, 2006 Primary completion: Dec 31, 2007 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Amyotrophic Lateral Sclerosis and Motor Neuron Disease, this trial is completed. The trial is conducted by Duke University and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Duke University
UCB Pharma

Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Durham, United States